Abstract
Competition for federal research funding has been widely cited as a factor in the incidence of scientific misconduct in the biomedical sciences. This commentary describes recent funding trends, including shifts in reviewers' scoring patterns, that may shed light on this issue.

This publication has 0 references indexed in Scilit: